TRIM14 and cancer: These results suggest that TRIM14 may be responsible for promoting cancer and CD8(+)T cell failure of TCF19 by activating TBK1/IRF3 and NF-κB pathways and maintaining high levels of IFN-β [38, 39] (Fig. 2A).